Found 49 hits with Last Name = 'bleasdale' and Initial = 'c' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093336
(6-(Thiophen-2-yloxy)-9H-purin-2-ylamine | CHEMBL33...)Show InChI InChI=1S/C9H7N5OS/c10-9-13-7-6(11-4-12-7)8(14-9)15-5-2-1-3-16-5/h1-4H,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5491
(6-(benzyloxy)-9H-purin-2-amine | CHEMBL407874 | O6...)Show InChI InChI=1S/C12H11N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB PubMed
| n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5491
(6-(benzyloxy)-9H-purin-2-amine | CHEMBL407874 | O6...)Show InChI InChI=1S/C12H11N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5484
(6-(cyclopent-1-en-1-ylmethoxy)-9H-purin-2-amine | ...)Show InChI InChI=1S/C11H13N5O/c12-11-15-9-8(13-6-14-9)10(16-11)17-5-7-3-1-2-4-7/h3,6H,1-2,4-5H2,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5484
(6-(cyclopent-1-en-1-ylmethoxy)-9H-purin-2-amine | ...)Show InChI InChI=1S/C11H13N5O/c12-11-15-9-8(13-6-14-9)10(16-11)17-5-7-3-1-2-4-7/h3,6H,1-2,4-5H2,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093328
(6-(Cyclobut-1-enylmethoxy)-9H-purin-2-ylamine | CH...)Show InChI InChI=1S/C10H11N5O/c11-10-14-8-7(12-5-13-8)9(15-10)16-4-6-2-1-3-6/h2,5H,1,3-4H2,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5486
(6-(cyclohex-1-en-1-ylmethoxy)-9H-purin-2-amine | C...)Show InChI InChI=1S/C12H15N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h4,7H,1-3,5-6H2,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50241513
((R)-6-((4-(prop-1-en-2-yl)cyclohex-1-enyl)methoxy)...)Show SMILES CC(=C)[C@@H]1CCC(COc2nc(N)nc3nc[nH]c23)=CC1 |c:20| Show InChI InChI=1S/C15H19N5O/c1-9(2)11-5-3-10(4-6-11)7-21-14-12-13(18-8-17-12)19-15(16)20-14/h3,8,11H,1,4-7H2,2H3,(H3,16,17,18,19,20)/t11-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5475
(6-(prop-2-en-1-yloxy)-9H-purin-2-amine | CHEMBL325...)Show InChI InChI=1S/C8H9N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h2,4H,1,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells . |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5475
(6-(prop-2-en-1-yloxy)-9H-purin-2-amine | CHEMBL325...)Show InChI InChI=1S/C8H9N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h2,4H,1,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 5.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells . |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5475
(6-(prop-2-en-1-yloxy)-9H-purin-2-amine | CHEMBL325...)Show InChI InChI=1S/C8H9N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h2,4H,1,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5472
(6-(prop-2-yn-1-yloxy)-9H-purin-2-amine | CHEMBL270...)Show InChI InChI=1S/C8H7N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h1,4H,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.15E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5472
(6-(prop-2-yn-1-yloxy)-9H-purin-2-amine | CHEMBL270...)Show InChI InChI=1S/C8H7N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h1,4H,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.19E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5476
(6-[(2-methylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C9H11N5O/c1-5(2)3-15-8-6-7(12-4-11-6)13-9(10)14-8/h4H,1,3H2,2H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.35E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells . |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5476
(6-[(2-methylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C9H11N5O/c1-5(2)3-15-8-6-7(12-4-11-6)13-9(10)14-8/h4H,1,3H2,2H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.35E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells . |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5477
(6-(2-methylidenebutoxy)-9H-purin-2-amine | CHEMBL2...)Show InChI InChI=1S/C10H13N5O/c1-3-6(2)4-16-9-7-8(13-5-12-7)14-10(11)15-9/h5H,2-4H2,1H3,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5472
(6-(prop-2-yn-1-yloxy)-9H-purin-2-amine | CHEMBL270...)Show InChI InChI=1S/C8H7N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h1,4H,3H2,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5476
(6-[(2-methylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C9H11N5O/c1-5(2)3-15-8-6-7(12-4-11-6)13-9(10)14-8/h4H,1,3H2,2H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5479
(6-[(2-phenylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C14H13N5O/c1-9(10-5-3-2-4-6-10)7-20-13-11-12(17-8-16-11)18-14(15)19-13/h2-6,8H,1,7H2,(H3,15,16,17,18,19) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.75E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5479
(6-[(2-phenylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C14H13N5O/c1-9(10-5-3-2-4-6-10)7-20-13-11-12(17-8-16-11)18-14(15)19-13/h2-6,8H,1,7H2,(H3,15,16,17,18,19) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.96E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5479
(6-[(2-phenylprop-2-en-1-yl)oxy]-9H-purin-2-amine |...)Show InChI InChI=1S/C14H13N5O/c1-9(10-5-3-2-4-6-10)7-20-13-11-12(17-8-16-11)18-14(15)19-13/h2-6,8H,1,7H2,(H3,15,16,17,18,19) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093325
(1-(2-Amino-9H-purin-6-yloxy)-butan-2-one | CHEMBL3...)Show InChI InChI=1S/C9H11N5O2/c1-2-5(15)3-16-8-6-7(12-4-11-6)13-9(10)14-8/h4H,2-3H2,1H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 9.32E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093325
(1-(2-Amino-9H-purin-6-yloxy)-butan-2-one | CHEMBL3...)Show InChI InChI=1S/C9H11N5O2/c1-2-5(15)3-16-8-6-7(12-4-11-6)13-9(10)14-8/h4H,2-3H2,1H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 9.45E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5481
(1-[(2-amino-9H-purin-6-yl)oxy]propan-2-one | CHEMB...)Show InChI InChI=1S/C8H9N5O2/c1-4(14)2-15-7-5-6(11-3-10-5)12-8(9)13-7/h3H,2H2,1H3,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 9.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5481
(1-[(2-amino-9H-purin-6-yl)oxy]propan-2-one | CHEMB...)Show InChI InChI=1S/C8H9N5O2/c1-4(14)2-15-7-5-6(11-3-10-5)12-8(9)13-7/h3H,2H2,1H3,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 9.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5464
(6-(heptyloxy)-9H-purin-2-amine | CHEMBL270945 | O6...)Show InChI InChI=1S/C12H19N5O/c1-2-3-4-5-6-7-18-11-9-10(15-8-14-9)16-12(13)17-11/h8H,2-7H2,1H3,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093325
(1-(2-Amino-9H-purin-6-yloxy)-butan-2-one | CHEMBL3...)Show InChI InChI=1S/C9H11N5O2/c1-2-5(15)3-16-8-6-7(12-4-11-6)13-9(10)14-8/h4H,2-3H2,1H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.51E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5481
(1-[(2-amino-9H-purin-6-yl)oxy]propan-2-one | CHEMB...)Show InChI InChI=1S/C8H9N5O2/c1-4(14)2-15-7-5-6(11-3-10-5)12-8(9)13-7/h3H,2H2,1H3,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.92E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5470
(6-methoxy-9H-purin-2-amine | CHEMBL226395 | O6-Sub...)Show InChI InChI=1S/C6H7N5O/c1-12-5-3-4(9-2-8-3)10-6(7)11-5/h2H,1H3,(H3,7,8,9,10,11) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2.48E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in intact HT-29 human colorectal carcinoma cells |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5470
(6-methoxy-9H-purin-2-amine | CHEMBL226395 | O6-Sub...)Show InChI InChI=1S/C6H7N5O/c1-12-5-3-4(9-2-8-3)10-6(7)11-5/h2H,1H3,(H3,7,8,9,10,11) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | 4.28E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5462
(6-butoxy-9H-purin-2-amine | CHEMBL270946 | O6-Subs...)Show InChI InChI=1S/C9H13N5O/c1-2-3-4-15-8-6-7(12-5-11-6)13-9(10)14-8/h5H,2-4H2,1H3,(H3,10,11,12,13,14) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 4.93E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5496
(6-(2-phenylethoxy)-9H-purin-2-amine | CHEMBL446625...)Show InChI InChI=1S/C13H13N5O/c14-13-17-11-10(15-8-16-11)12(18-13)19-7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H3,14,15,16,17,18) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 5.48E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093343
(6-Hexyloxy-9H-purin-2-ylamine | CHEMBL338451)Show InChI InChI=1S/C11H17N5O/c1-2-3-4-5-6-17-10-8-9(14-7-13-8)15-11(12)16-10/h7H,2-6H2,1H3,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 5.54E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5501
(6-(2,2-diethoxypropoxy)-9H-purin-2-amine | CHEMBL4...)Show InChI InChI=1S/C12H19N5O3/c1-4-19-12(3,20-5-2)6-18-10-8-9(15-7-14-8)16-11(13)17-10/h7H,4-6H2,1-3H3,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50241514
(6-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-9H-pur...)Show InChI InChI=1S/C11H15N5O3/c1-11(2)18-4-6(19-11)3-17-9-7-8(14-5-13-7)15-10(12)16-9/h5-6H,3-4H2,1-2H3,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5469
(6-(3-methylbutoxy)-9H-purin-2-amine | CHEMBL269872...)Show InChI InChI=1S/C10H15N5O/c1-6(2)3-4-16-9-7-8(13-5-12-7)14-10(11)15-9/h5-6H,3-4H2,1-2H3,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5502
(6-(2,2-dimethoxybutoxy)-9H-purin-2-amine | CHEMBL4...)Show InChI InChI=1S/C11H17N5O3/c1-4-11(17-2,18-3)5-19-9-7-8(14-6-13-7)15-10(12)16-9/h6H,4-5H2,1-3H3,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093331
(2-(2-Amino-9H-purin-6-yloxy)-1-phenyl-ethanone | C...)Show InChI InChI=1S/C13H11N5O2/c14-13-17-11-10(15-7-16-11)12(18-13)20-6-9(19)8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,14,15,16,17,18) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093347
(6-Hex-3-enyloxy-9H-purin-2-ylamine | CHEMBL129960)Show InChI InChI=1S/C11H15N5O/c1-2-3-4-5-6-17-10-8-9(14-7-13-8)15-11(12)16-10/h3-4,7H,2,5-6H2,1H3,(H3,12,13,14,15,16)/b4-3- | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5485
(6-(cyclohexylmethoxy)-9H-purin-2-amine | CHEMBL269...)Show InChI InChI=1S/C12H17N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h7-8H,1-6H2,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5483
(6-(cyclopentylmethoxy)-9H-purin-2-amine | CHEMBL27...)Show InChI InChI=1S/C11H15N5O/c12-11-15-9-8(13-6-14-9)10(16-11)17-5-7-3-1-2-4-7/h6-7H,1-5H2,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093345
(6-(2,2-Dimethoxy-2-phenyl-ethoxy)-9H-purin-2-ylami...)Show InChI InChI=1S/C15H17N5O3/c1-21-15(22-2,10-6-4-3-5-7-10)8-23-13-11-12(18-9-17-11)19-14(16)20-13/h3-7,9H,8H2,1-2H3,(H3,16,17,18,19,20) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5487
(6-(cyclohex-3-en-1-ylmethoxy)-9H-purin-2-amine | C...)Show InChI InChI=1S/C12H15N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-2,7-8H,3-6H2,(H3,13,14,15,16,17) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5461
(6-propoxy-9H-purin-2-amine | CHEMBL272692 | O6-Sub...)Show InChI InChI=1S/C8H11N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h4H,2-3H2,1H3,(H3,9,10,11,12,13) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5471
(6-ethoxy-9H-purin-2-amine | CHEMBL406419 | O6-Subs...)Show InChI InChI=1S/C7H9N5O/c1-2-13-6-4-5(10-3-9-4)11-7(8)12-6/h3H,2H2,1H3,(H3,8,9,10,11,12) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM50093340
(6-Cyclobutylmethoxy-9H-purin-2-ylamine | CHEMBL133...)Show InChI InChI=1S/C10H13N5O/c11-10-14-8-7(12-5-13-8)9(15-10)16-4-6-2-1-3-6/h5-6H,1-4H2,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5478
(6-(3-methyl-2-methylidenebutoxy)-9H-purin-2-amine ...)Show InChI InChI=1S/C11H15N5O/c1-6(2)7(3)4-17-10-8-9(14-5-13-8)15-11(12)16-10/h5-6H,3-4H2,1-2H3,(H3,12,13,14,15,16) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5482
(1-[(2-amino-9H-purin-6-yl)oxy]-3-methylbutan-2-one...)Show InChI InChI=1S/C10H13N5O2/c1-5(2)6(16)3-17-9-7-8(13-4-12-7)14-10(11)15-9/h4-5H,3H2,1-2H3,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL DrugBank MMDB PC cid PC sid PDB UniChem
Similars
| PubMed
| n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description concentration required to reduce AGT activity to 50% of control rate in HT-29 cell extract. |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |
Methylated-DNA--protein-cysteine methyltransferase
(Homo sapiens (Human)) | BDBM5463
(6-(pentyloxy)-9H-purin-2-amine | CHEMBL406495 | O6...)Show InChI InChI=1S/C10H15N5O/c1-2-3-4-5-16-9-7-8(13-6-12-7)14-10(11)15-9/h6H,2-5H2,1H3,(H3,11,12,13,14,15) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.01E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
The University
Curated by ChEMBL
| Assay Description Inhibition of AGT activity to 50% of control rate in HT-29 cell extract |
J Med Chem 43: 4071-83 (2000)
BindingDB Entry DOI: 10.7270/Q2RF5T8B |
More data for this Ligand-Target Pair | |